Evidence map›Paper›PMID 32678836›Full record

ArticlePLoS pathogens2020

Inhibition of spumavirus gene expression by PHF11.

Melissa Kane, Vincent Mele, Rachel A Liberatore, Paul D Bieniasz

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. TheViruses · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Melissa KaneDepartment of Pediatrics, Infectious Diseases Division, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0002-4580-1210
Vincent MeleDepartment of Pediatrics, Infectious Diseases Division, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Rachel A LiberatoreLaboratory of Retrovirology, The Rockefeller University, New York, New York, United States of America.ORCID 0000-0002-3861-5858
Paul D BieniaszLaboratory of Retrovirology, The Rockefeller University, New York, New York, United States of America.ORCID 0000-0002-2368-3719
Howard Hughes Medical Institute · USUniversity of Pittsburgh · US

Funding

Discovery and Mechanism of Antiretroviral FactorsR37AI064003 · NIAID · ROCKEFELLER UNIVERSITY · PI BIENIASZ, PAUL D. · 2011 to 2020
$4.9M
Retrovirus Restriction by Trima5alphaR01AI064003 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI BIENIASZ, PAUL D. · 2005 to 2009
$2.1M
Mechanism of lentiviral inhibition by Mx2F32AI116263 · NIAID · ROCKEFELLER UNIVERSITY · PI KANE, MELISSA E · 2015 to 2017
$179k
NIAID NIH HHS F32 AI116263NIAID NIH HHS R37 AI064003
6 · The paper itself

Abstract

The foamy viruses (FV) or spumaviruses are an ancient subfamily of retroviruses that infect a variety of vertebrates. FVs are endemic, but apparently apathogenic, in modern non-human primates. Like other retroviruses, FV replication is inhibited by type-I interferon (IFN). In a previously described screen of IFN-stimulated genes (ISGs), we identified the macaque PHD finger domain protein-11 (PHF11) as an inhibitor of prototype foamy virus (PFV) replication. Here, we show that human and macaque PHF11 inhibit the replication of multiple spumaviruses, but are inactive against several orthoretroviruses. Analysis of other mammalian PHF11 proteins revealed that antiviral activity is host species dependent. Using multiple reporter viruses and cell lines, we determined that PHF11 specifically inhibits a step in the replication cycle that is unique to FVs, namely basal transcription from the FV internal promoter (IP). In so doing, PHF11 prevents expression of the viral transactivator Tas and subsequent activation of the viral LTR promoter. These studies reveal a previously unreported inhibitory mechanism in mammalian cells, that targets a family of ancient viruses and may promote viral latency.

Indexed as

AnimalsDNA-Binding ProteinsHumansMacacaRetroviridae InfectionsSpumavirusTranscription FactorsVirus LatencyVirus ReplicationDNA-Binding ProteinsPHF11 protein, humanTranscription Factors

Identifiers

PMID32678836
PMCPMC7390438
OpenAlexW3042834419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.